U 84793
Alternative Names: FK-2PLatest Information Update: 15 Jun 1995
At a glance
- Originator Pharmacia Corporation
- Class Thrombolytics
- Mechanism of Action Plasminogen activator inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
Most Recent Events
- 15 Jun 1995 No-Development-Reported for Thrombosis in USA (Unknown route)